Work

Abstract CT153: First in human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2017-ct153

Authors: Gerald Falchook, Manish Patel, Jeffrey Infante, Hendrik-Tobias Arkenau, Emma Dean, Andrew Brenner, Erkut Borazanci, Juanita Lopez, Kathleen Moore, Peter Schmid, Arthur Frankel, Suzanne Jones, William McCulloch, George Kemble, Howard Burris

Institutions: HealthONE, Sarah Cannon, Tennessee Oncology, Sarah Cannon Research Institute, University of Manchester, The Christie NHS Foundation Trust, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, St Bartholomew's Hospital, The University of Texas Southwestern Medical Center

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2740630567

Cites:

Cited by: 25

Related to: 10